Composition
- Active ingredients
- METHYLDOPA 250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- METHYLDOPA 250MG/5ML · SuspensionNDA018389-001 · Discontinued
- METHYLDOPA 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · TabletNDA013400-002 · Discontinued
- METHYLDOPA 125MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · TabletNDA013400-003 · Discontinued
- METHYLDOPA 250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · TabletThis page
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA013400.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Aldomet
- Active substance
- methyldopa
- Route
- Oral
- Dosage form
- Tablet
- Applicant
- Merck
- Status
- Discontinued
- FDA approval
- 20 Dec 1962
- Application
- NDA013400-001